Illicit trade in Smokeless Products and the risks of its undermining global Tobacco Harm Reduction

Aerial view of illuminated cargo ship loading colorful shipping containers at night
17 September 2024

CHAPTER 7 . THR: GLOBAL REGULATION

Illicit trade in Smokeless Products and the risks of it undermining global Tobacco Harm Reduction

Words by

The prominence of Smokeless Products in many markets has grown rapidly over a relatively short space of time (<10 years), with large numbers of smokers switching to these products. Unfortunately, alongside the Tobacco Harm Reduction (THR) positives from the growth seen in regulated products, there has also been a substantial rise in the availability of illicit products.


The prominence of Smokeless Products in many markets has grown rapidly over a relatively short space of time (<10 years), with large numbers of smokers switching to these products. Unfortunately, alongside the Tobacco Harm Reduction (THR) positives from the growth seen in regulated products, there has also been a substantial rise in the availability of illicit products.

Whilst we have seen relatively lower amounts of illicit products in Oral Nicotine Pouches and Heated Products, we have witnessed the substantial rise in unregulated illicit Vapour Products alongside counterfeits of our brands. These unregulated products may pose an additional risk to consumers, as most assume them to be genuine. As these illicit Smokeless Products are not subject to the high-quality manufacturing standards required for regulated products, they are unlikely to be stewarded to optimise their safety profile and, in some cases, the ingredients added to these products may be acutely harmful to human health.

A particularly concerning example of illicit products were those that triggered the EVALI (E-cigarette or Vaping Use-Associated Lung Injury) crisis in 2019,[1] where Vitamin E Acetate was used in an e-liquid solution as a carrier for cannabis-based ingredients. The presence of these illegal Vapour Products in the U.S. caused over 2,800 hospitalisations and 68 deaths.[2]

Typically, illicit products do not conform to regulatory product specifications, with many illicit Oral Nicotine Pouches found to have increased levels of nicotine over that stated on the pack. Illicit Vapour Products can have illegal flavours that particularly appeal to the underaged, as well as nicotine levels or liquid fill volumes that exceed the regulatory market limit. Such products not only present an additional risk to consumers, but also lead to growing calls for greater restrictions and regulations imposed on the relevant Smokeless Product category as a result.

The prominence of Vapour Products has grown significantly across the world, and according to ECigIntelligence, the category is currently worth USD 30 billion, with over 65 million consumers worldwide.[3] A consequence of this growth has also been the growth in illicit Vapour Products.

"The number of unique e-cigarettes sold in the U.S. has mushroomed to over 9,000 since 2020, when the FDA began restricting vaping flavors and requiring manufacturers to request permission to stay on the market. […] The increase in e-cigarettes has been almost entirely driven by Chinese-manufactured disposables, with more than 5,800 disposables currently being sold in U.S. stores, according to the IRI data. That number is up more than 1,500% from 356 disposables available in early 2020."

 

Associated Press News
‘5 takeaways from the AP’s report on Chinese disposable e-cigarettes flooding the U.S market’ 2023[5]

The illicit vaping market is yet to be fully quantified, a reason for this is the multiple ways in which Vapour Products could be defined as illicit, which creates challenges for law enforcement and other stakeholders. Broadly speaking, illicit vaping can be divided into four segments:

 

Product restrictions

  • Some countries have outright bans on sales of Vapour Products, such as Brazil. In Brazil, all sales of vapes are illicit, but its market value is over USD 800 million, all of which is criminal profits. We do not supply Smokeless Products to Brazil, but the continued growth in the category illustrates how consumers are able to obtain Vapour Products, which are not controlled through regulatory or fiscal measures.
  • Many countries around the world have product restrictions, such as vaping tank size and nicotine content limits as well as ingredient bans which restrict flavours. In the UK, it appears that over a quarter of products exceed tank size limits and are therefore illicit, and in many markets such as the U.S., which have not authorised any flavoured products other than tobacco and menthol flavours, most consumers continue to purchase illicit flavoured products. The presence of illicit products undermines Tobacco Harm Reduction efforts across the world.

 

Retail restriction

  • Some countries ban the online sale of Vapour Products, but this does not stop retailers from outside the country offering illicit products through online retail channels. In some EU countries which ban online sales, more than half of all web traffic relating to Vapour Products is to foreign retailers which is very difficult to enforce against. In the Netherlands, a third of vape consumers continue to purchase illicit products online, and in Belgium, one in five similarly purchase illicit products online.

 

Administrative review and market authorisations 

  • A large number of products are often placed onto the market without complying with the relevant administrative controls. This can be identified through reviewing the significant trade gaps that exist between the value of Vapour Products exported to the U.S. and the UK from China, compared with the value of products tracked by Customs authorities. Such analysis indicates that more than 80% of Vapour Products imported into the U.S. are not tracked. This is consistent with an estimate of over 95% of the market lacking FDA authorisation or a court order allowing the product to remain on the market, therefore classifying it as illicit. In the EU, the volume of products notified and listed on a centralised database makes it very difficult for enforcement agencies in each country to check compliance. This leads to high volumes of illicit products. With unauthorised products that often do not comply with product requirements flooding the market, the ability for compliant manufacturers like BAT to compete on level terms is significantly undermined.

 

Tax

  • There is increasing evidence that the amount of tax revenue that should be collected where Vapour Products are taxed goes unpaid. In the EU, of the ten Member States who applied tax to Vapour Products in 2022, seven collected less than half of the tax due. Furthermore, countries which collected less tax often had more complex regulatory regimes, meaning that consumers turned elsewhere to obtain their products.

The fact that existing controls on Vapour Products are undermined in so many ways creates a complex illicit landscape and an unlevel playing field between compliant manufacturers (like BAT and others) and other non-compliant companies who are selling these products illegally. In many of the countries mentioned, illicit trade in Vapour Products can be above 50% (one in every two products, if not totally illicit in prohibition markets, e.g. Brazil), which is significantly higher than global estimates for illicit tobacco at approximately one in every ten cigarettes and tobacco products.[4]

Without proper enforcement of existing regulations and a greater focus on illicit trade of Smokeless Products, efforts to help smokers switch will be compromised. Furthermore, the presence of non-compliant or potentially dangerous products in completely unregulated illicit markets undermine global Tobacco Harm Reduction efforts. This emphasises the importance of developing new policy solutions to help regulators and enforcement to combat illicit trade of Smokeless Products.

References
[1] American Lung Association, E-cigarette or Vaping Use-Associated Lung Injury (EVALI). Available at:  https://www.lung.org/lung-health-diseases/lung-disease-lookup/evali (Accessed: 31 July 2024)

[2] Triantafyllou, G.A., et al., Long-term outcomes of EVALI: a 1-year retrospective study. Lancet, 2021. 9(12), p.e112. DOI:10.1016/S2213-2600(21)00415-X

[3] ECigIntelligence, Regulatory & Market Intelligence for the e-Cigarette Sector, ECigIntelligence market database, July Report. 2024.

[4] Ulep, V.G., et al. Measuring the capacity to combat illicit tobacco trade in 160 countries. Global Health, 2021. 17, 130. DOI: 10.1186/s12992-021-00783-4

[5]AP News, 5 takeaways from the AP’s report on Chinese disposable e-cigarettes flooding the US market. 2023. Available at: https://apnews.com/article/fda-vapes-vaping-elf-bar-juul-5e45cf57dc78f6b94213047c97b10f7e (Accessed: 7 August 2024)

Sign up for more exclusive the Omni™ content